SEC Form 4 · accession 0001123292-15-000128
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard T Kenney
Officer — Chief Medical Officer
Period of report
Jan 7, 2015
Accepted (ET)
Jan 9, 2015 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $31.00 | Jan 7, 2015 | A | 30,000 | A | — | Jan 7, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The shares issuable upon exercise of the options to purchase common stock held by the Reporting Person are subject to a 180-day lockup agreement entered into by the Reporting Person in connection with the Issuer's initial public offering.
- F2One quarter of the shares underlying the option will vest on January 1, 2016, and the remainder of the shares vest at a rate of 1/36th per month thereafter.